Cambria Investment Management »

Keros Therapeutics shares owned by Cambria Investment Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Cambria Investment Management from 13F filings

Historical chart of Cambria Investment Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Cambria Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Cambria Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $638k 31k 20.36

More positions owned by Cambria Investment Management

Cambria Etf Tr Cambria Fgn Shr (FYLD)
Cambria Etf Tr Global Value Etf (GVAL)
Cambria Etf Tr Emrg Sharehldr (EYLD)
Cambria Etf Tr Value Momentum (VAMO)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Cambria Etf Tr Gbl Real Est Etf (BLDG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Spdr Series Trust Bloomberg Enhncd (CERY)
Exxon Mobil Corporation (XOM)
Cambria Etf Tr Glb Moment Etf (GMOM)
Graniteshares Gold Tr Shs Ben Int (BAR)
Tidal Trust Ii Cambria Chesapea (MFUT)
Litman Gregory Fds Tr Imgp Dbi Managed (DBMF)
Invesco Db Multi-sector Comm Precious Metal (DBP)

View all positions for Cambria Investment Management

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
State Street Corporation
Alkeon Capital Management
Madison Avenue Partners
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Geode Capital Management
Nantahala Capital Management
Renaissance Technologies
Goldman Sachs Group

View all funds holding Keros Therapeutics